Literature DB >> 30955519

Sarcoidosis.

Oscar Llanos1, Nabeel Hamzeh2.   

Abstract

Sarcoidosis is a multisystemic granulomatous disease that affects individuals worldwide. The lungs are most commonly involved but any organ can be involved. It has variable manifestations and clinical course. Diagnosis of sarcoidosis is based on clinicopathologic findings and the exclusion of other causes of granulomatous disease. Its hallmark is the formation of granulomas in affected organs. Immunosuppressive therapy is the cornerstone of the management of sarcoidosis and is indicated when there is evidence of symptomatic or progressive disease or when critical organs (ocular, cardiac, nervous system) are involved.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Nonnecrotizing granuloma; Organ involvement; Sarcoidosis

Mesh:

Year:  2019        PMID: 30955519     DOI: 10.1016/j.mcna.2018.12.011

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  15 in total

1.  Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.

Authors:  Arzu Cennet Işık; Murat Kavas; Mehmet Engin Tezcan
Journal:  Z Rheumatol       Date:  2022-04-26       Impact factor: 1.372

2.  Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.

Authors:  Abdullah Sakkat; Gerard Cox; Nader Khalidi; Maggie Larche; Karen Beattie; Elisabetta A Renzoni; Nilesh Morar; Vasilis Kouranos; Martin Kolb; Nathan Hambly
Journal:  Respir Res       Date:  2022-03-09

Review 3.  Sarcoidosis and Its Dermatological Manifestations: A Narrative Review.

Authors:  Jancy Koneti; Swathi Priya Cherukuri; Sai Gadde; Revanth Kalluru; Rahul Chikatimalla; Thejaswi Dasaradhan
Journal:  Cureus       Date:  2022-08-16

4.  Testicular Sarcoidosis: An Underdiagnosed Manifestation That Poses Unique Challenges.

Authors:  Ujval S Choksi; Gurdeep Singh
Journal:  Cureus       Date:  2022-06-14

5.  Novel three-dimensional biochip pulmonary sarcoidosis model.

Authors:  Tess M Calcagno; Chongxu Zhang; Runxia Tian; Babak Ebrahimi; Mehdi Mirsaeidi
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

6.  Rapidly recurring massive pleural effusion as the initial presentation of sarcoidosis: A case report.

Authors:  Mutaz Albakri; Mushtaq Ahmad; Mouhand F H Mohamed
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

Review 7.  Mimickers of Large Vessel Giant Cell Arteritis.

Authors:  André Ramon; Hélène Greigert; Paul Ornetti; Bernard Bonnotte; Maxime Samson
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

8.  Treatment-recalcitrant laryngeal sarcoidosis responsive to sirolimus.

Authors:  Karen J Kelleher; John Russell; Orla G Killeen; Timothy Ronan Leahy
Journal:  BMJ Case Rep       Date:  2020-08-26

9.  Autoimmune diseases - New insights into a troublesome field.

Authors:  Thomas Lung; Benjamin Sakem; Andreas Hemmerle; Michèle Nydegger; Martin Risch; Lorenz Risch; Urs Nydegger
Journal:  J Transl Autoimmun       Date:  2021-06-01

10.  Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkers.

Authors:  Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Fabrizio Mezzasalma; Rosa Metella Refini; Maria Pieroni; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Immunol       Date:  2021-07-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.